As biologics gain greater prominence, protein engineers are adapting to new indications, new advances in targeting science, new product formats, and products that are truly differentiated in the marketplace. The Protein Engineering & Development pipeline offers a weeklong exploration of state-of-the-art approaches for developing safe and effective protein and antibody-based therapeutics, including improving product qualities, optimizing lead and candidate selection, and the application of deep sequencing and single cell analysis.

January 20-21

Recombinant Protein Therapeutics

January 21-22

Lead and Candidate Selection for Therapeutic Proteins

January 23-24

Deep Sequencing and Single Cell Analysis for Antibody Discovery

Keynote Speakers

Aris N. Economides, PhD, Vice President, Research, Regeneron Pharmaceuticals, Inc.

Peter M. Tessier, PhD, Professor, Pharmaceutical Sciences, Chemical Engineering and Biomedical Engineering, University of Michigan

Bryan Briney, PhD, Assistant Professor, Immunology and Microbiology, The Scripps Research Institute


2020 Conferences & Training Seminars